Tag obesity drugs

News

Eli Lilly Tightens Its Grip on the Obesity Drug Market as Rivals Scramble to Catch Up

Eli Lilly corporate office building surrounded by trees and landscaping on a sunny day.

Eli Lilly entered June 2026 with something most pharmaceutical companies spend years chasing: clinical data so compelling that competitors can barely keep pace. At the American Diabetes Association’s annual Scientific Sessions, the company unveiled extended trial results for retatrutide. Clinicians,…

Adeeba
June 11, 2026

News

Novo Nordisk Gets EU Backing for Wegovy Pill, Beats Eli Lilly to the Punch

Sign outside Lilly Research Laboratories campus with autumn trees and a modern office building in the background.

European drug regulators handed Novo Nordisk a major win. Specifically, the date was May 22, 2026. The Committee for Medicinal Products for Human Use (CHMP) works under the European Medicines Agency (EMA). Notably, it backed once-daily oral semaglutide 25 mg,…

Adeeba
May 24, 2026